ORTINLABSS

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding 'Newspaper Publication'.

Ortin Laboratories Limited has informed the Exchange regarding 'Intimation'.

Ortin Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 21, 2019 to September 30, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on September 30, 2019.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

Ortin Laboratories Limited has informed the Exchange regarding 'Compliance of Regulation 23(9) of SEBI (LODR) Regulations'.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

Ortin Laboratories Limited has informed the Exchange regarding 'Company��s Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information has been amended in accordance with the provisions of the SEBI (prohibition of Insider Trading) (Amended) Regulations, 2018. The revised Code is made available on the website of the Company'.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2018. Further, the company has informed the Exchange regarding voting results.

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018

Ortin Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 22, 2018 to September 29, 2018 (both days inclusive) for the purpose of Annual General Meeting to be held on September 29, 2018.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

Ortin Laboratories Limited has informed the Exchange regarding Cessation of Mr Mathpati Tippayya as Non- Executive Independent Director of the company w.e.f. July 30, 2018.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

The Exchange had sought clarification from Ortin Laboratories Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is enclosed.

ORTINLABSS:The Exchange had sought clarification from Ortin Laboratories Limited with respect to announcement dated 27-Apr-2018, regarding " Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on April 27, 2018.".On basis of above the Company is required to clarify following:1. Disclosure of relationships between directors (in case of appointment of a director).<br>The response of the Company is enclosed.

ORTINLABSS:The Exchange has sought clarification from Ortin Laboratories Limited with respect to announcement dated 27-Apr-2018, regarding " Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on April 27, 2018.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).<br> The response of the Company is awaited.

Ortin Laboratories Limited has informed the Exchange regarding Board meeting held on April 27, 2018.

SBICAP Trustee Company Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ortin Laboratories Limited has informed the Exchange regarding change in Registered Office of the company.

Ortin Laboratories Limited has informed the Exchange regarding 'Newspaper publication for the quarter ended 31.12.2017'.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2017.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding Appointment of Company Secretary & Compliance Officer.

The Exchange has sought clarification from Ortin Laboratories Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted as per Schedule III to the Companies Act, 2013 The response of the Company is awaited.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Ortin Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.

Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2017. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended 30-Jun-2017.

Ortin Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015The trading window in respect of the Company s Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on 06.09.2017 till close of the trading hours on 16.09.2017 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended 30.06.2017.

Ortin Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2017.

Ortin Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on September 29, 2017

Ortin Laboratories Limited has informed the Exchange regarding '1. 30th Annual General Meeting of the Company for the year 2016-17 will be held on Friday, 29th day of September, 2017 at 11:00 A.M. at the Registered Office of the Company at D. No: 1-2-593/29, Ground Floor, Street No.4, Gagan Mahal Colony, Domalguda, Hyderabad, 500029, Telangana.2. Closure of the Register of Members and Share Transfer Books from Saturday, the 23rd September, 2017 to Friday, 29th September, 2017 (both days inclusive).3. Appointment of M/s Vivek Surana & Associates, Practicing Company

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.

Ortin Laboratories Limited has informed the Exchange regarding Closure of Trading Window for the audited Financial results for the quarter and year ended March 31, 2017.

S Murali Krishna Murthy has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Ortin Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.

Ortin Laboratories Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on February 14, 2017.

Ortin Laboratories Limited has informed the Exchange that the trading window in respect of the Company's securities shall remain closed for all the Directors/Officers/Designed Employees of the company from the trading hours on February 03, 2017 till close of the trading hours on February 16, 2017 as per the code of internal procedure and Conduct for prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended December 31, 2016.